These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8610652)
1. Episcleral plaque thermoradiotherapy of posterior uveal melanomas. Petrovich Z; Pike M; Astrahan MA; Luxton G; Murphree AL; Liggett PE Am J Clin Oncol; 1996 Apr; 19(2):207-11. PubMed ID: 8610652 [TBL] [Abstract][Full Text] [Related]
2. Episcleral plaque thermoradiotherapy in patients with choroidal melanoma. Petrovich Z; Astrahan MA; Luxton G; Green R; Langholz B; Liggett P Int J Radiat Oncol Biol Phys; 1992; 23(3):599-603. PubMed ID: 1612961 [TBL] [Abstract][Full Text] [Related]
3. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas. Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118 [TBL] [Abstract][Full Text] [Related]
4. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy. Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215 [TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes. Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808 [TBL] [Abstract][Full Text] [Related]
6. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control. Quivey JM; Augsburger J; Snelling L; Brady LW Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107 [TBL] [Abstract][Full Text] [Related]
12. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques. Puusaari I; Heikkonen J; Kivelä T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045 [TBL] [Abstract][Full Text] [Related]
13. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [TBL] [Abstract][Full Text] [Related]
14. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604 [TBL] [Abstract][Full Text] [Related]
15. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool. Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414 [TBL] [Abstract][Full Text] [Related]